WeightWatchers Is Gambling Everything on Obesity Drugs
July 20, 2023
The WeightWatchers brand has had a long and evolving history since its inception in 1963, transitioning from a strict weight-loss plan to a wellness-focused program. In recent years, faced with declining membership and competition from digital weight-loss platforms, WeightWatchers enlisted Oprah Winfrey’s endorsement to revamp its image and appeal. However, in a bold move, the company’s new CEO, Sima Sistani, is now betting on obesity drugs, particularly GLP-1s, by acquiring Sequence, a telemedicine provider that can offer these medications. This move has sparked controversy among some longtime members, who see it as a shift away from the traditional program’s values, while others are hopeful that the combination of GLP-1s and WeightWatchers’ support services will provide a new approach to tackling obesity.
Recent News
Top Deals for National Hamburger Day 2024
National Hamburger Day 2024 is just around the corner, falling on Tuesday, May 28.
Bass Pro Shops CEO Focuses on Affordability Amid Inflation
In response to the persistent inflation affecting the economy, Johnny Morris, the founder and CEO of Bass Pro Shops, has reaffirmed the brand’s commitment to affordability. With inflation currently at 3.4%, above the Federal Reserve’s 2% target, Morris acknowledged the reality of rising costs and emphasized that the hunting, fishing, and outdoor sporting brand will maintain its focus on delivering value to its customers.
European Central Bank Set To Cut Interest Rates Next Week
The European Central Bank (ECB) is poised to reduce interest rates in its upcoming meeting, marking a significant shift in monetary policy aimed at addressing the current economic landscape.
China Is Spending $47.5 Billion for Chip Industry
China is significantly bolstering its semiconductor industry with a historic investment of $47.5 billion, reflecting its strategic push to become a global leader in advanced technology.